[Federal Register: November 29, 2005 (Volume 70, Number 228)]
[Notices]
[Page 71559]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29no05-96]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 18, 2005, Dade Behring
Inc., 100 GBE Drive, MS514, Post Office Box 6101, Attention: RA/QS,
Newark, Delaware 19714-6101, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabionols (7370).............. I
Benzoylecgonine (9180)..................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to produce the listed controlled substances in
bulk to be used in the manufacture of reagents and drug calibrator/
controls for DEA exempt products.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters,
Attention: DEA Federal Register Representative/ODL, 2401 Jefferson
Davis Highway, Alexandria, Virginia 22301; and must be filed no later
than January 30, 2006.
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. E5-6603 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P